The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Inbrain will apply Microsoft's agentic AI and cloud tech to its brain-computer interface, which could facilitate faster treatment based on what's happening in the brain at that moment.

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.